Loading...
Loading...
Among the 2 tracked institutional investors we monitor, APLSUSD (APELLIS PHARMACEUTICALS INC) is held with a combined value of $270.94M across 10,785,765 shares. The largest holder is VANGUARD GROUP INC with a position worth $268.15M. TWO SIGMA ADVISERS, LP opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$270.94M
Total Shares Held
10,785,765
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
None this quarter.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $268.15M | 0.00% | +6.9% |
| 2 | TWO SIGMA ADVISERS, LP | $2.79M | 0.01% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of APLSUSD with a position worth $268.15M, representing 0.00% of their portfolio. In total, 2 institutional investors hold APLSUSD with a combined value of $270.94M.
In the most recent quarter, 1 fund opened a new position in APLSUSD. Additionally, 1 increased their holdings.
Institutional investors hold $270.94M worth of APLSUSD stock across 2 positions. The largest institutional holder is VANGUARD GROUP INC with $268.15M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For APLSUSD, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their APLSUSD positions.